Diana Ayán

Study of Rivaroxaban for Cerebral Venous Thrombosis: A Randomized Controlled Feasibility Trial Comparing Anticoagulation With Rivaroxaban to Standard-of-Care in Symptomatic Cerebral Venous Thrombosis

Thalia S. Field, Vanessa Dizonno, Mohammed Almekhlafi et al. · Stroke · 2023 · 65 citations · Full text

Impact of estradiol structural modifications (18-methyl and/or 17-hydroxy inversion of configuration) on the in vitro and in vivo estrogenic activity

Diana Ayán, Jenny Roy, René Maltais et al. · The Journal of Steroid Biochemistry and Molecular Biology · 2011 · 56 citations

Biochemistry, Vivo Estrogenic Activity, Medicine +11

Identification of a 17β‐Hydroxysteroid Dehydrogenase Type 10 Steroidal Inhibitor: A Tool to Investigate the Role of Type 10 in Alzheimer’s Disease and Prostate Cancer

Diana Ayán, René Maltais, Donald Poirier · ChemMedChem · 2012 · 49 citations

A New Nonestrogenic Steroidal Inhibitor of 17β-Hydroxysteroid Dehydrogenase Type I Blocks the Estrogen-Dependent Breast Cancer Tumor Growth Induced by Estrone

Diana Ayán, René Maltais, Jenny Roy et al. · Molecular Cancer Therapeutics · 2012 · 42 citations · Full text

Breast Oncology, Chemoprevention Strategy, Mammary Gland Development +22

Differences in Stroke Recurrence Risk Between Atrial Fibrillation Detected on ECG and 14-Day Cardiac Monitoring

Alonso Alvarado‐Bolaños, Diana Ayán, Alexander V. Khaw et al. · Stroke · 2023 · 34 citations · Full text